The impact of biologic therapies on extra-intestinal manifestations in inflammatory bowel disease: A multicenter study

INTRODUCTION: Patients with inflammatory bowel disease (IBD) have a high risk of developing extra-intestinal manifestations (EIMs). We aimed to assess the cumulative incidence and clinical course of EIMs in patients treated with Vedolizumab (VDZ) and non-gut selective biologic drugs. MATERIALS AND M...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferretti, Francesca, Monico, Maria Camilla, Cannatelli, Rosanna, Carmagnola, Stefania, Lenti, Marco Vincenzo, Di Sabatino, Antonio, Conforti, Francesco, Pastorelli, Luca, Caprioli, Flavio, Bezzio, Cristina, Saibeni, Simone, Mazza, Stefano, Vecchi, Maurizio, Maconi, Giovanni, Ardizzone, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393583/
https://www.ncbi.nlm.nih.gov/pubmed/36004370
http://dx.doi.org/10.3389/fmed.2022.933357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393583/
https://www.ncbi.nlm.nih.gov/pubmed/36004370
http://dx.doi.org/10.3389/fmed.2022.933357

Ejemplares similares